Seeking Alpha

  Celgene Corporation - NASDAQ

11/24/2014, 12:38 AM ET
  • The Scientist | Send Message 31 Jul 2012

    Awaiting CELG Abraxane data on panc CA. SPARC hypothesis controversial. Abrax does not improve OS in breast CA, which is usually SPARC+.
    Reply (2)
    • The Scientist | Send Message 31 Jul 2012
      : Perhaps destroying SPARC/stroma promotes metastasis - allows for easier malignant cell escape. Abrax should have worked better in breast CA.
    • Noreika | Send Message 31 Jul 2012
      : Off topic: Did ILNS.PK get halted today? I can't wait to see the Study 301 results!! (the non-carrier one) Or was it the Study 300?
      CELG vs. ETF Alternatives
      Company Description
      Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States